These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31269262)

  • 1. Heritable Genome Editing in a Global Context: National and International Policy Challenges.
    Rosemann A; Balen A; Nerlich B; Hauskeller C; Sleeboom-Faulkner M; Hartley S; Zhang X; Lee N
    Hastings Cent Rep; 2019 May; 49(3):30-42. PubMed ID: 31269262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsible governance of human germline genome editing in China†.
    Peng Y; Lv J; Ding L; Gong X; Zhou Q
    Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Governance of Heritable Human Gene Editing World-Wide and Beyond.
    Xue Y; Shang L
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Experts Are Not Enough.
    Hurlbut JB
    Hastings Cent Rep; 2019 May; 49(3):43-44. PubMed ID: 31269259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges to effective governance in a low income healthcare system: a qualitative study of stakeholder perceptions in Malawi.
    Masefield SC; Msosa A; Grugel J
    BMC Health Serv Res; 2020 Dec; 20(1):1142. PubMed ID: 33317520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kenyan health stakeholder views on individual consent, general notification and governance processes for the re-use of hospital inpatient data to support learning on healthcare systems.
    Mbuthia D; Molyneux S; Njue M; Mwalukore S; Marsh V
    BMC Med Ethics; 2019 Jan; 20(1):3. PubMed ID: 30621693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Germ Line and Heritable Genome Editing: The Global Policy Landscape.
    Baylis F; Darnovsky M; Hasson K; Krahn TM
    CRISPR J; 2020 Oct; 3(5):365-377. PubMed ID: 33095042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights?
    Halpern J; O'Hara SE; Doxzen KW; Witkowsky LB; Owen AL
    CRISPR J; 2019 Oct; 2(5):293-298. PubMed ID: 31599687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genome editing: how to prevent rogue actors.
    Townsend BA
    BMC Med Ethics; 2020 Oct; 21(1):95. PubMed ID: 33023591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A virtual deliberative public engagement study on heritable genome editing among South Africans: Study protocol.
    Thaldar D; Townsend B; Botes M; Shozi B; Pillay S
    PLoS One; 2021; 16(8):e0256097. PubMed ID: 34411176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making sense of heritable human genome editing: Scientific and ethical considerations.
    Greenfield A
    Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Governance Approach to Regulating Human Genome Editing.
    Conley JM; Davis AM; Henderson GE; Juengst ET; Meagher KM; Walker RL; Waltz M; Cadigan J
    N C J Law Technol; 2020 Dec; 22(2):107-141. PubMed ID: 34737680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Democratic Governance of Human Germline Genome Editing.
    Jasanoff S; Hurlbut JB; Saha K
    CRISPR J; 2019 Oct; 2(5):266-271. PubMed ID: 31599682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ugandan stakeholder hopes and concerns about gene drive mosquitoes for malaria control: new directions for gene drive risk governance.
    Hartley S; Smith RDJ; Kokotovich A; Opesen C; Habtewold T; Ledingham K; Raymond B; Rwabukwali CB
    Malar J; 2021 Mar; 20(1):149. PubMed ID: 33726763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Should We Regulate Heritable Human Genome Editing in Australia?
    Nicol D; Rudge C; Paxton R; Niemeyer S
    J Law Med; 2022 Jun; 29(2):322-336. PubMed ID: 35819374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholder engagement in the health policy process in a low income country: a qualitative study of stakeholder perceptions of the challenges to effective inclusion in Malawi.
    Masefield SC; Msosa A; Chinguwo FK; Grugel J
    BMC Health Serv Res; 2021 Sep; 21(1):984. PubMed ID: 34537033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research.
    Waltz M; Juengst ET; Edwards T; Henderson GE; Kuczynski KJ; Conley JM; Della-Penna P; Cadigan RJ
    CRISPR J; 2021 Aug; 4(4):609-615. PubMed ID: 34406038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholder Involvement in the Governance of Human Genome Editing in Japan.
    Aikyo T; Kogetsu A; Kato K
    Asian Bioeth Rev; 2023 Oct; 15(4):431-455. PubMed ID: 37808450
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.